|
RNASEN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.256400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.732300E-02 |
| Normal-vs-Stage2 |
7.319900E-02 |
| Normal-vs-Stage3 |
4.045200E-04 |
| Normal-vs-Stage4 |
3.221500E-04 |
| Stage1-vs-Stage2 |
4.592800E-01 |
| Stage1-vs-Stage3 |
1.530190E-02 |
| Stage1-vs-Stage4 |
1.718370E-02 |
| Stage2-vs-Stage3 |
3.620400E-01 |
| Stage2-vs-Stage4 |
2.978200E-01 |
| Stage3-vs-Stage4 |
8.857000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.524700E-03 |
| Normal-vs-AfricanAmerican |
5.920200E-03 |
| Normal-vs-Asian |
4.181600E-01 |
| Caucasian-vs-AfricanAmerican |
5.253600E-01 |
| Caucasian-vs-Asian |
1.390360E-01 |
| AfricanAmerican-vs-Asian |
6.746100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.016370E-03 |
| Normal-vs-Female |
2.151500E-02 |
| Male-vs-Female |
3.555800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.201600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.980200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.391940E-02 |
| Normal-vs-Age(81-100Yrs) |
2.367500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.335220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.628300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.432800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.247600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.983240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.491950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.881400E-01 |
| Normal-vs-Grade 2 |
5.801900E-02 |
| Normal-vs-Grade 3 |
9.187400E-04 |
| Normal-vs-Grade 4 |
3.71310000000236E-05 |
| Grade 1-vs-Grade 2 |
4.247800E-01 |
| Grade 1-vs-Grade 3 |
1.828760E-01 |
| Grade 1-vs-Grade 4 |
2.713600E-02 |
| Grade 2-vs-Grade 3 |
6.356200E-02 |
| Grade 2-vs-Grade 4 |
2.476700E-03 |
| Grade 3-vs-Grade 4 |
1.448420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.995620E-01 |
| Normal-vs-ccB subtype |
2.324000E-03 |
| ccA subtype-vs-ccB subtype |
4.694100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.138140E-02 |
| Normal-vs-N1 |
6.252500E-02 |
| N0-vs-N1 |
6.529800E-01 |
|
|
